Flu (Influenza) Vaccine Market, Global Outlook and Forecast 2023-2029

Report ID: MMG174494 | Category: Pharma & Healthcare | Pages: 73 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
This report aims to provide a comprehensive presentation of the global market for Flu (Influenza) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu (Influenza) Vaccine. This report contains market size and forecasts of Flu (Influenza) Vaccine in global, including the following market information:
Global Flu (Influenza) Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Flu (Influenza) Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Flu (Influenza) Vaccine companies in 2022 (%)
The global Flu (Influenza) Vaccine market was valued at US$ 5664.4 million in 2022 and is projected to reach US$ 7180 million by 2029, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent. 
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Flu (Influenza) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Flu (Influenza) Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Flu (Influenza) Vaccine Market Segment Percentages, by Type, 2022 (%)
    Split Influenza Vaccine
    Pandemic Influenza Vaccine
    Subunit Influenza Vaccine
    Quadrivalent Influenza Vaccine
Global Flu (Influenza) Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Flu (Influenza) Vaccine Market Segment Percentages, by Application, 2022 (%)
    For Children (6 months to 3 years)
    For Adults and Children over 3 years
Global Flu (Influenza) Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Flu (Influenza) Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Flu (Influenza) Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Flu (Influenza) Vaccine revenues share in global market, 2022 (%)
Key companies Flu (Influenza) Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Flu (Influenza) Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Hualan Bio
    CCBIO
    Aleph Biomedical
    SANOFI
    Adimmune
    ZYAK
    SINOVAC
    Changsheng Biological
    SIOBP
    GSK
    Aimei Hissen
    Tianyuan Bio-pharma(Novartis)
    Simcere Vaxtec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Flu (Influenza) Vaccine, market overview.
Chapter 2: Global Flu (Influenza) Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Flu (Influenza) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Flu (Influenza) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Flu (Influenza) Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Flu (Influenza) Vaccine Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Flu (Influenza) Vaccine Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Flu (Influenza) Vaccine Overall Market Size
    2.1 Global Flu (Influenza) Vaccine Market Size: 2022 VS 2029
    2.2 Global Flu (Influenza) Vaccine Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Flu (Influenza) Vaccine Sales: 2018-2029
3 Company Landscape
    3.1 Top Flu (Influenza) Vaccine Players in Global Market
    3.2 Top Global Flu (Influenza) Vaccine Companies Ranked by Revenue
    3.3 Global Flu (Influenza) Vaccine Revenue by Companies
    3.4 Global Flu (Influenza) Vaccine Sales by Companies
    3.5 Global Flu (Influenza) Vaccine Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Flu (Influenza) Vaccine Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Flu (Influenza) Vaccine Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Flu (Influenza) Vaccine Players in Global Market
        3.8.1 List of Global Tier 1 Flu (Influenza) Vaccine Companies
        3.8.2 List of Global Tier 2 and Tier 3 Flu (Influenza) Vaccine Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Flu (Influenza) Vaccine Market Size Markets, 2022 & 2029
        4.1.2 Split Influenza Vaccine
        4.1.3 Pandemic Influenza Vaccine
        4.1.4 Subunit Influenza Vaccine
        4.1.5 Quadrivalent Influenza Vaccine
    4.2 By Type - Global Flu (Influenza) Vaccine Revenue & Forecasts
        4.2.1 By Type - Global Flu (Influenza) Vaccine Revenue, 2018-2023
        4.2.2 By Type - Global Flu (Influenza) Vaccine Revenue, 2024-2029
        4.2.3 By Type - Global Flu (Influenza) Vaccine Revenue Market Share, 2018-2029
    4.3 By Type - Global Flu (Influenza) Vaccine Sales & Forecasts
        4.3.1 By Type - Global Flu (Influenza) Vaccine Sales, 2018-2023
        4.3.2 By Type - Global Flu (Influenza) Vaccine Sales, 2024-2029
        4.3.3 By Type - Global Flu (Influenza) Vaccine Sales Market Share, 2018-2029
    4.4 By Type - Global Flu (Influenza) Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Flu (Influenza) Vaccine Market Size, 2022 & 2029
        5.1.2 For Children (6 months to 3 years)
        5.1.3 For Adults and Children over 3 years
    5.2 By Application - Global Flu (Influenza) Vaccine Revenue & Forecasts
        5.2.1 By Application - Global Flu (Influenza) Vaccine Revenue, 2018-2023
        5.2.2 By Application - Global Flu (Influenza) Vaccine Revenue, 2024-2029
        5.2.3 By Application - Global Flu (Influenza) Vaccine Revenue Market Share, 2018-2029
    5.3 By Application - Global Flu (Influenza) Vaccine Sales & Forecasts
        5.3.1 By Application - Global Flu (Influenza) Vaccine Sales, 2018-2023
        5.3.2 By Application - Global Flu (Influenza) Vaccine Sales, 2024-2029
        5.3.3 By Application - Global Flu (Influenza) Vaccine Sales Market Share, 2018-2029
    5.4 By Application - Global Flu (Influenza) Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Flu (Influenza) Vaccine Market Size, 2022 & 2029
    6.2 By Region - Global Flu (Influenza) Vaccine Revenue & Forecasts
        6.2.1 By Region - Global Flu (Influenza) Vaccine Revenue, 2018-2023
        6.2.2 By Region - Global Flu (Influenza) Vaccine Revenue, 2024-2029
        6.2.3 By Region - Global Flu (Influenza) Vaccine Revenue Market Share, 2018-2029
    6.3 By Region - Global Flu (Influenza) Vaccine Sales & Forecasts
        6.3.1 By Region - Global Flu (Influenza) Vaccine Sales, 2018-2023
        6.3.2 By Region - Global Flu (Influenza) Vaccine Sales, 2024-2029
        6.3.3 By Region - Global Flu (Influenza) Vaccine Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Flu (Influenza) Vaccine Revenue, 2018-2029
        6.4.2 By Country - North America Flu (Influenza) Vaccine Sales, 2018-2029
        6.4.3 US Flu (Influenza) Vaccine Market Size, 2018-2029
        6.4.4 Canada Flu (Influenza) Vaccine Market Size, 2018-2029
        6.4.5 Mexico Flu (Influenza) Vaccine Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Flu (Influenza) Vaccine Revenue, 2018-2029
        6.5.2 By Country - Europe Flu (Influenza) Vaccine Sales, 2018-2029
        6.5.3 Germany Flu (Influenza) Vaccine Market Size, 2018-2029
        6.5.4 France Flu (Influenza) Vaccine Market Size, 2018-2029
        6.5.5 U.K. Flu (Influenza) Vaccine Market Size, 2018-2029
        6.5.6 Italy Flu (Influenza) Vaccine Market Size, 2018-2029
        6.5.7 Russia Flu (Influenza) Vaccine Market Size, 2018-2029
        6.5.8 Nordic Countries Flu (Influenza) Vaccine Market Size, 2018-2029
        6.5.9 Benelux Flu (Influenza) Vaccine Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Flu (Influenza) Vaccine Revenue, 2018-2029
        6.6.2 By Region - Asia Flu (Influenza) Vaccine Sales, 2018-2029
        6.6.3 China Flu (Influenza) Vaccine Market Size, 2018-2029
        6.6.4 Japan Flu (Influenza) Vaccine Market Size, 2018-2029
        6.6.5 South Korea Flu (Influenza) Vaccine Market Size, 2018-2029
        6.6.6 Southeast Asia Flu (Influenza) Vaccine Market Size, 2018-2029
        6.6.7 India Flu (Influenza) Vaccine Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Flu (Influenza) Vaccine Revenue, 2018-2029
        6.7.2 By Country - South America Flu (Influenza) Vaccine Sales, 2018-2029
        6.7.3 Brazil Flu (Influenza) Vaccine Market Size, 2018-2029
        6.7.4 Argentina Flu (Influenza) Vaccine Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Flu (Influenza) Vaccine Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Flu (Influenza) Vaccine Sales, 2018-2029
        6.8.3 Turkey Flu (Influenza) Vaccine Market Size, 2018-2029
        6.8.4 Israel Flu (Influenza) Vaccine Market Size, 2018-2029
        6.8.5 Saudi Arabia Flu (Influenza) Vaccine Market Size, 2018-2029
        6.8.6 UAE Flu (Influenza) Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Hualan Bio
        7.1.1 Hualan Bio Company Summary
        7.1.2 Hualan Bio Business Overview
        7.1.3 Hualan Bio Flu (Influenza) Vaccine Major Product Offerings
        7.1.4 Hualan Bio Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.1.5 Hualan Bio Key News & Latest Developments
    7.2 CCBIO
        7.2.1 CCBIO Company Summary
        7.2.2 CCBIO Business Overview
        7.2.3 CCBIO Flu (Influenza) Vaccine Major Product Offerings
        7.2.4 CCBIO Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.2.5 CCBIO Key News & Latest Developments
    7.3 Aleph Biomedical
        7.3.1 Aleph Biomedical Company Summary
        7.3.2 Aleph Biomedical Business Overview
        7.3.3 Aleph Biomedical Flu (Influenza) Vaccine Major Product Offerings
        7.3.4 Aleph Biomedical Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.3.5 Aleph Biomedical Key News & Latest Developments
    7.4 SANOFI
        7.4.1 SANOFI Company Summary
        7.4.2 SANOFI Business Overview
        7.4.3 SANOFI Flu (Influenza) Vaccine Major Product Offerings
        7.4.4 SANOFI Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.4.5 SANOFI Key News & Latest Developments
    7.5 Adimmune
        7.5.1 Adimmune Company Summary
        7.5.2 Adimmune Business Overview
        7.5.3 Adimmune Flu (Influenza) Vaccine Major Product Offerings
        7.5.4 Adimmune Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.5.5 Adimmune Key News & Latest Developments
    7.6 ZYAK
        7.6.1 ZYAK Company Summary
        7.6.2 ZYAK Business Overview
        7.6.3 ZYAK Flu (Influenza) Vaccine Major Product Offerings
        7.6.4 ZYAK Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.6.5 ZYAK Key News & Latest Developments
    7.7 SINOVAC
        7.7.1 SINOVAC Company Summary
        7.7.2 SINOVAC Business Overview
        7.7.3 SINOVAC Flu (Influenza) Vaccine Major Product Offerings
        7.7.4 SINOVAC Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.7.5 SINOVAC Key News & Latest Developments
    7.8 Changsheng Biological
        7.8.1 Changsheng Biological Company Summary
        7.8.2 Changsheng Biological Business Overview
        7.8.3 Changsheng Biological Flu (Influenza) Vaccine Major Product Offerings
        7.8.4 Changsheng Biological Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.8.5 Changsheng Biological Key News & Latest Developments
    7.9 SIOBP
        7.9.1 SIOBP Company Summary
        7.9.2 SIOBP Business Overview
        7.9.3 SIOBP Flu (Influenza) Vaccine Major Product Offerings
        7.9.4 SIOBP Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.9.5 SIOBP Key News & Latest Developments
    7.10 GSK
        7.10.1 GSK Company Summary
        7.10.2 GSK Business Overview
        7.10.3 GSK Flu (Influenza) Vaccine Major Product Offerings
        7.10.4 GSK Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.10.5 GSK Key News & Latest Developments
    7.11 Aimei Hissen
        7.11.1 Aimei Hissen Company Summary
        7.11.2 Aimei Hissen Flu (Influenza) Vaccine Business Overview
        7.11.3 Aimei Hissen Flu (Influenza) Vaccine Major Product Offerings
        7.11.4 Aimei Hissen Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.11.5 Aimei Hissen Key News & Latest Developments
    7.12 Tianyuan Bio-pharma(Novartis)
        7.12.1 Tianyuan Bio-pharma(Novartis) Company Summary
        7.12.2 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Business Overview
        7.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Major Product Offerings
        7.12.4 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.12.5 Tianyuan Bio-pharma(Novartis) Key News & Latest Developments
    7.13 Simcere Vaxtec
        7.13.1 Simcere Vaxtec Company Summary
        7.13.2 Simcere Vaxtec Flu (Influenza) Vaccine Business Overview
        7.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Major Product Offerings
        7.13.4 Simcere Vaxtec Flu (Influenza) Vaccine Sales and Revenue in Global (2018-2023)
        7.13.5 Simcere Vaxtec Key News & Latest Developments
8 Global Flu (Influenza) Vaccine Production Capacity, Analysis
    8.1 Global Flu (Influenza) Vaccine Production Capacity, 2018-2029
    8.2 Flu (Influenza) Vaccine Production Capacity of Key Manufacturers in Global Market
    8.3 Global Flu (Influenza) Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Flu (Influenza) Vaccine Supply Chain Analysis
    10.1 Flu (Influenza) Vaccine Industry Value Chain
    10.2 Flu (Influenza) Vaccine Upstream Market
    10.3 Flu (Influenza) Vaccine Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Flu (Influenza) Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Flu (Influenza) Vaccine Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?